NOVO-B.CO in “America Imports the World's Drug Prices”
Novo Nordisk A/S
Large gaps between US and European obesity-drug prices make Novo Nordisk a prominent reference-pricing target.
NOVO-B.CO impact map — “America Imports the World's Drug Prices”
How this story travels from the headline to NOVO-B.CO’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading NOVO-B.CO impact map…
Price history, marked with story events
Oct 20, 2025 – Oct 19, 2026 · 245 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
America Imports the World's Drug Prices
US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
BEAR side — Large gaps between US and European obesity-drug prices make Novo Nordisk a prominent reference-pricing target.
Read the full America Imports the World's Drug Prices storyBull side
0 storiesNo bull-side stories for NOVO-B.CO yet.
Bear side
2 stories- The Dollar Loses Its Exceptionalism
NOVO-B.CO in “The Dollar Loses Its Exceptionalism”
AcceleratingExposure: not rated yetFiscal risk and narrowing rate differentials are redirecting capital toward non-dollar assets and punishing currency-sensitive exporters.
Novo Nordisk earns substantial US revenue in dollars while reporting in Danish kroner, creating a translation headwind when the dollar weakens.
- Viewing
NOVO-B.CO in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Large gaps between US and European obesity-drug prices make Novo Nordisk a prominent reference-pricing target.